Aclara BioSciences Inc., of Mountain View, Calif., appointed Jose Baselga to its scientific advisory board.
Acrongenomics Inc., of Calgary, Alberta, appointed Alexander Vamvakides to its board and a member of the scientific committee.
Alfacell Corp., of Bloomfield, N.J., appointed Andrew Aromando senior vice president of commercial development and operations, and named David Sidransky to its board.
Align Technology Inc., of Santa Clara, Calif., appointed Warren Thaler to its board.
Alpharma Inc., of Fort Lee, N.J., elected Ramon Perez to its board, and made Ingrid Wiik vice chairman of the board.
Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Michael Wyzga to its board and chairman of the audit and finance committee.
Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, elected Glen Nelson, Edward Brown and Arthur Willms to its board.
Aptamera Inc., of Louisville, Ky., appointed Donald Kufe to its board and chairman of its scientific advisory board.
Argonaut Technologies Inc., of Foster City, Calif., re-elected Lissa Goldenstein to its board.
Avitar Inc., of Canton, Mass., appointed David Greaves vice president of sales.
BioTime Inc., of Berkeley, Calif., appointed Jeffrey Nickel vice president of business development and marketing.
BioTrove Inc., of Woburn, Mass., appointed Alan Barber chief financial officer.
Cardinal Health Inc., of Dublin, Ohio, appointed John Parker president of a UK-based management team.
Cellerant Therapeutics Inc., of Palo Alto, Calif., appointed Timothy Fong vice president of research, and Linda Rogers senior director of global clinical operations.
CeMines Inc., of Evergreen, Colo., appointed David Busam vice president of finance and administration and chief financial officer.
Cerco Medical, of San Francisco, formerly called Islet Sheet Medical LLC, appointed Kurt Amundson vice president and chief financial officer.
Cholestech Corp., of Hayward, Calif., appointed Kenneth Miller vice president of sales and marketing.
CyDex Inc., of Lenexa, Kan., appointed Joseph Fix president and chief operating officer.
Discovery Laboratories Inc., of Doylestown, Pa., appointed Mark Osterman senior vice president of sales and marketing.
Edwards Lifesciences Corp., of Irvine, Calif., appointed Patrick Verguet president of Edwards Europe.
Genencor International Inc., of Palo Alto, Calif., said its chairman, president and CEO, Jean-Jacques Bienaime, was named to the Biotechnology Industry Organization's board.
Genetronics Biomedical Corp., of San Diego, appointed Michael Fons executive director of corporate development.
GenoMed Inc., of St. Louis, appointed Paula Hempen chief scientific officer.
Geospiza Inc., of Seattle, appointed Kevin Banks vice president of business development.
InGenium Research Inc., of Cary, N.C., appointed Jamie Oliver chief operations officer and head of development.